Conor D. Collins - Concepedia

Author

Conor D. Collins

Also Known As

C Collins, C D Collins, C. Collins, C. D. Collins, C., Collins, C.D. Collins, CONOR D. COLLINS, Christopher E. Collins, Conor Collins, Conor D Collins

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

St. Vincent's University Hospital The Christie Hospital Cancer Trials Ireland University Hospital Waterford Cork University Hospital

About

Conor D. Collins is an author at St. Vincent's University Hospital specializing in medicine, oncology, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	19	25	1.1K
2	Health Sciences	14	16	667
3	Engineering	3	3	75
4	Gastroenterology	3	3	73
5	Biostatistics	1	1	32

Conor D. Collins

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Samarium-153-EDTMP biodistribution and dosimetry estimation. Janet F. Eary, Conor D. Collins, Michael Stabin, PubMed OsteoporosisRadiation MedicineOncologyRadiopharmaceutical TherapyRadiation Therapy Planning	1993	226
Radiotherapy for muscle-invasive carcinoma of the bladder: results of a randomized trial comparing conventional whole bladder with dose-escalated partial bladder radiotherapy Richard Cowan, Catherine McBain, W. David J. Ryder, International Journal of Radiation OncologyBiologyPhysics UrologySurgical OncologyUrologic Cancer EpidemiologyRadiation TherapyGenitourinary Cancer	2004	148
Pulmonary Embolism in Pregnancy: Comparison of Pulmonary CT Angiography and Lung Scintigraphy Carole A. Ridge, Shaunagh McDermott, Bridget Freyne, American Journal of Roentgenology	2009	128
Magnetic Resonance Imaging in the Management of Suspected Spinal Canal Disease in Patients with Known Malignancy GARETH J. LOUGHREY, Conor D. Collins, S M Todd, Clinical Radiology Neuro-oncologyKnown MalignancySpinal Cord InjuryMedical ImagingSpinal Tumor	2000	73
A phase I clinical and pharmacokinetic study of the multi-drug resistance protein-1 (MRP-1) inhibitor sulindac, in combination with epirubicin in patients with advanced cancer Robert O’Connor, Michael P. O’Leary, J. Ballot, Cancer Chemotherapy and Pharmacology Advanced CancerOncologyHealth SciencesMedicineImmune Checkpoint Inhibitor	2006	63
Escalated dose for non-small-cell lung cancer with accelerated hypofractionated three-dimensional conformal radiation therapy P. Thirion, Ola Holmberg, Conor D. Collins, Radiotherapy and Oncology Radiation MedicineNon-small-cell Lung CancerRadiation TherapyMedicineRadiation Therapy Planning	2004	53
Multiple myeloma Conor D. Collins Cancer Imaging	2004	50
First evidence of a therapeutic effect of miransertib in a teenager with Proteus syndrome and ovarian carcinoma Chiara Leoni, Giuseppe Gullo, Nicoletta Resta, American Journal of Medical Genetics Part A	2019	48
Pelvic arterial embolization following hysterectomy and bilateral internal iliac artery ligation for intractable primary post partum haemorrhage Conor D. Collins, James E. Jackson Clinical Radiology Pelvic TraumaGynecologyVascular SurgeryPelvic Arterial EmbolizationVascular Trauma	1995	42
Assay of anti-cancer drugs in tissue culture: Relationship of relapse free interval (RFI) and in vitro chemosensitivity in patients with malignant cerebral glioma D. G. T. Thomas, John L. Darling, E. Paul, British Journal of Cancer Neuro-oncologyMedicinePharmacologyRelapse Free IntervalHigh-grade Gliomas	1985	41

Page 1